ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ABIO ARCA Biopharma Inc

4.29
0.59 (15.95%)
プレマーケット
最終更新日: 17:40:55
15分遅延
名称 銘柄コード 市場 種別
ARCA Biopharma Inc ABIO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.59 15.95% 4.29 17:40:55
始値 安値 高値 終値 前日終値
3.70
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2304:08PRNUSKuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to..
2024/4/2605:15GLOBEARCA biopharma Announces First Quarter 2024 Financial..
2024/4/0602:09PRNUSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to..
2024/4/0320:30GLOBEARCA biopharma and Oruka Therapeutics Announce Merger..
2024/2/0803:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0706:15EDGAR2Form 8-K - Current report
2024/2/0206:39EDGAR2Form 8-K - Current report
2024/2/0206:35GLOBEARCA biopharma Announces 2023 Financial Results
2024/2/0206:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/0108:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:15EDGAR2Form 8-K - Current report
2023/12/2006:25EDGAR2Form ARS - Annual Report to Security Holders
2023/12/2006:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2006:15EDGAR2Form DEF 14A - Other definitive proxy statements
2023/12/0606:25EDGAR2Form 8-K - Current report
2023/12/0506:36EDGAR2Form 8-K - Current report
2023/10/1905:35EDGAR2Form 8-K - Current report
2023/10/1905:25GLOBEARCA biopharma Announces Third Quarter 2023 Financial..
2023/10/1905:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/9/1205:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/7/2205:35EDGAR2Form 8-K - Current report
2023/7/2205:25GLOBEARCA biopharma Announces Second Quarter 2023 Financial..
2023/7/2205:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]